ASX:JHCJapara Healthcare Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Japara Healthcare Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add A$0.59 +0.01 (+1.72 %) (As of 05/13/2020) Add Compare Share Today's RangeA$0.57Now: A$0.59▼A$0.6050-Day RangeA$0.59MA: A$0.59▼A$0.5952-Week RangeA$0.38Now: A$0.59▼A$1.25Volume505,569 shsAverage Volume666,254 shsMarket Capitalization$157.68 millionP/E Ratio11.13Dividend Yield7.62%BetaN/A ProfileAdvanced ChartCompetitorsDividendEarningsInsider TradesHeadlines Japara Healthcare Limited, together with its subsidiaries, owns, develops, and operates residential aged care facilities in Australia. It operates approximately 5,400 resident places across 48 homes located in Victoria, New South Wales, Queensland, South Australia, and Tasmania; and 180 independent living units across 5 retirement villages. The company was founded in 2005 and is based in Southbank, Australia.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Japara Healthcare. Previous Next 2.2 Community Rank Outperform VotesJapara Healthcare has received 45 “outperform” votes. (Add your “outperform” vote.)Underperform VotesJapara Healthcare has received 55 “underperform” votes. (Add your “underperform” vote.)Community SentimentJapara Healthcare has received 55.00% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Japara Healthcare and other stocks. Vote “Outperform” if you believe JHC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe JHC will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 1.7 Dividend Strength Dividend LeadershipJapara Healthcare is a leading dividend payer. It pays a dividend yield of 7.62%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthJapara Healthcare does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Japara Healthcare is 75.47%. Payout ratios above 75% are not desirable because they may not be sustainable. Previous Next 3.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Japara Healthcare insiders have bought more of their company's stock than they have sold. Specifically, they have bought A$6,699.00 in company stock and sold A$0.00 in company stock. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Japara Healthcare are expected to decrease by -100.00% in the coming year, from A$0.13 to A$0.00 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Japara Healthcare is 11.13, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 16.84.Price to Earnings Ratio vs. SectorThe P/E ratio of Japara Healthcare is 11.13, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.37.Price to Book Value per Share RatioJapara Healthcare has a P/B Ratio of 0.30. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 1.7Insider Behavior: 3.0Valuation: 1.9 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.75 out of 5 stars Industry, Sector and Symbol Stock Exchange ASX Industry Long-Term Care Facilities Sub-IndustryN/A SectorMedical Current SymbolASX:JHC Previous Symbol CUSIPN/A CIKN/A Webjaparahealthcare.com.au Phone+61-3-96492100Debt Debt-to-Equity Ratio50.51 Current Ratio0.12 Quick Ratio0.10Price-To-Earnings Trailing P/E Ratio11.13 Forward P/E Ratio4.38 P/E GrowthN/A Sales & Book Value Annual Sales$408.64 million Price / Sales0.39 Cash FlowA$0.19 per share Price / Cash Flow3.17 Book ValueA$1.95 per share Price / Book0.30Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares267,247,008Market Cap$157.68 million Next Earnings DateN/A OptionableNot Optionable Receive JHC News and Ratings via Email Sign-up to receive the latest news and ratings for JHC and its competitors with MarketBeat's FREE daily newsletter. Japara Healthcare (ASX:JHC) Frequently Asked Questions How has Japara Healthcare's stock been impacted by COVID-19 (Coronavirus)? Japara Healthcare's stock was trading at A$0.63 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, JHC shares have decreased by 6.3% and is now trading at A$0.59. View which stocks have been most impacted by Coronavirus. How were Japara Healthcare's earnings last quarter? Japara Healthcare Ltd (ASX:JHC) released its quarterly earnings results on Monday, August, 27th. The company reported $0.09 EPS for the quarter, beating the consensus estimate of $0.08 by $0.01. View Japara Healthcare's earnings history. How often does Japara Healthcare pay dividends? What is the dividend yield for Japara Healthcare? Japara Healthcare declared a Interim dividend on Monday, March 2nd. Stockholders of record on Thursday, April 30th will be paid a dividend of 0.02 per share on Thursday, April 30th. This represents a dividend yield of 2.22%. The ex-dividend date is Thursday, March 26th. View Japara Healthcare's dividend history. Has Japara Healthcare been receiving favorable news coverage? Press coverage about JHC stock has trended very negative this week, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Japara Healthcare earned a coverage optimism score of -3.2 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news about Japara Healthcare. Who are some of Japara Healthcare's key competitors? Some companies that are related to Japara Healthcare include Sienna Senior Living (SIA), Oceania Healthcare (OCA), Extendicare (EXE), Regis Healthcare (REG), Estia Health (EHE), Nova Leap Health (NLH), Regional Health Properties (RHE) and RYMAN HEALTHCAR/ADR (RYHTY). View all competitors. What other stocks do shareholders of Japara Healthcare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Japara Healthcare investors own include Aveo Group (AOG), G8 Education (GEM), Clipper Logistics (CLG), Commonwealth Bank of Australia (CBA), Citigroup (C), Boardwalk Pipeline Partners (BWP), BWP Trust (BWP), BTG (BTG), BRF (BRFS) and BHP Group (BHP). Who are Japara Healthcare's key executives? Japara Healthcare's management team includes the following people: Mr. Andrew Sudholz FPI, MAICD, MD, CEO & Exec. DirectorMr. Christopher Murray Price, CFO & Company Sec. (Age 54)Ashley van Winkel, Group Exec. of People & InfrastructureMr. Bruce Craig Paterson, Company Sec. What is Japara Healthcare's stock symbol? Japara Healthcare trades on the ASX under the ticker symbol "JHC." What is Japara Healthcare's stock price today? One share of JHC stock can currently be purchased for approximately A$0.59. How big of a company is Japara Healthcare? Japara Healthcare has a market capitalization of $157.68 million and generates $408.64 million in revenue each year. What is Japara Healthcare's official website? The official website for Japara Healthcare is japarahealthcare.com.au. How can I contact Japara Healthcare? Japara Healthcare's mailing address is Bldg, SE 1 L 4, 1 Southbank Bvd, SOUTHBANK, VIC 3006, Australia. The company can be reached via phone at +61-3-96492100. This page was last updated on 7/13/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
